Convalescent plasma is plasma that is already present in the body and includes anti-SARS-CoV-2 antibodies. This plasma includes antibodies that may kill viral particles, thereby preventing virus entrance into cells. This neutralizing procedure has an effect on the improvement of a patient's clinical state after receiving convalescent plasma treatment. The possibility of this convalescent plasma therapy as a treatment for individuals infected with SARS-CoV-2 has been evaluated, and clinical trials are still ongoing. The aim of this study is to determine the antibody titer of the donor. The research was a descriptive study. Total sample was 25 repeated male donors. The data of their IgM and IgG levels was obtained from Management Information ...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disea...
The outbreak of severe acute respiratory syndrome COVID-19 caused by SARS-CoV-2 in China represents ...
Convalescent plasma is plasma that is already present in the body and includes anti-SARS-CoV-2 antib...
Convalescent plasma (CP) has been in use for the treatment of numerous infectious diseases for more ...
International audienceBackground: Passive therapy with convalescent plasma (CP) could be an effectiv...
Severe acute respiratory syndrome (SARS-CoV-2) causes the 2019 Coronavirus Disease pandemic. Convale...
International audienceConvalescent plasma therapy has been described as an attractive approach to tr...
Immunosuppressed patients such as solid organ transplant and hematologic malignancy patients appear ...
BackgroundConvalescent plasma therapy is expected to be a promising alternative to supportive therap...
ObjectivesSerologic testing for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
Background We explored the outcome of convalescent plasma (CP) treatment in patients with moderate a...
Background/Aim. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) 2019 infection represe...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disea...
The outbreak of severe acute respiratory syndrome COVID-19 caused by SARS-CoV-2 in China represents ...
Convalescent plasma is plasma that is already present in the body and includes anti-SARS-CoV-2 antib...
Convalescent plasma (CP) has been in use for the treatment of numerous infectious diseases for more ...
International audienceBackground: Passive therapy with convalescent plasma (CP) could be an effectiv...
Severe acute respiratory syndrome (SARS-CoV-2) causes the 2019 Coronavirus Disease pandemic. Convale...
International audienceConvalescent plasma therapy has been described as an attractive approach to tr...
Immunosuppressed patients such as solid organ transplant and hematologic malignancy patients appear ...
BackgroundConvalescent plasma therapy is expected to be a promising alternative to supportive therap...
ObjectivesSerologic testing for antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
Background We explored the outcome of convalescent plasma (CP) treatment in patients with moderate a...
Background/Aim. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) 2019 infection represe...
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary do...
Convalescent plasma has emerged as a promising therapeutic agent for patients with coronavirus disea...
The outbreak of severe acute respiratory syndrome COVID-19 caused by SARS-CoV-2 in China represents ...